Welcome to CDC stacks | Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA - 28107

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA

Published Date:

Mar 2015

Publisher's site:

http://dx.doi.org/10.3201/eid2103.141313 New Site Icon

Source:

Emerg Infect Dis. 21(3):500-503.

[PDF-1.22 MB]

Details:

Personal Authors:

Trieu, Lisa ; Proops, Douglas C. ; Ahuja, Shama D. ;

Keywords:

[+]

Description:

Contacts of persons infected with multidrug-resistant tuberculosis (MDR TB) have few prophylaxis options. Of 50 contacts of HIV- and MDR TB-positive persons who were treated with moxifloxacin, 30 completed treatment and 3 discontinued treatment because of gastrointestinal symptoms. Moxifloxacin was generally well-tolerated; further research of its efficacy against MDR TB is needed.

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	14-1313.nxml	text/plain
	license.txt	text/plain

No Related Documents.

You May Also Like:

Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis

Personal Author:

Marks, Suzanne M.; Mase, Sundari R.; Morris, Sapna Bamrah;

Published:

Jun 15 2017

Source:

Clin Infect Dis. 64(12):1670-1677

Description:

Background : Evidence-based recommendations for treating persons having presumed latent tuberculosis (LTBI) after contact to infectious multidrug-resistant (MDR) tuberculosis (TB) are lacking because published data consist of small observational stud...

File Type:

[PDF - 193.88 KB]
Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis

Personal Author:

Osman, Muhammad; Harausz, Elizabeth P.; Garcia-Prats, Anthony J.; Schaaf, H. Simon; Moore, Brittany K.; Hicks, Robert M.; Achar, Jay; Amanullah, Farhana; Barry, Pennan; Becerra, Mercedes; Chiotan, Domnica I.; Drobac, Peter C.; Flood, Jennifer; Furin, Jennifer; Gegia, Medea; Isaakidis, Petros; Mariandyshev, Andrei; Ozere, Iveta; Shah, N. Sarita; Skrahina, Alena; Yablokova, Elena; Seddon, James A.; Hesseling, Anneke C.;

Corporate Author:

for The Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR TB

Published:

Mar 2019

Source:

Emerg Infect Dis. 25(3):441-450

Description:

Extensively drug-resistant tuberculosis (XDR TB) has extremely poor treatment outcomes in adults. Limited data are available for children. We report on clinical manifestations, treatment, and outcomes for 37 children (<15 years of age) with bacteriol...

File Type:

[PDF - 961.79 KB]
Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru

Personal Author:

Nathavitharana, Ruvandhi R.; Shi, Cynthia X.; Chindelevitch, Leonid; Calderon, Roger; Zhang, Zibiao; Galea, Jerome T.; Contreras, Carmen; Yataco, Rosa; Lecca, Leonid; Becerra, Mercedes C.; Murray, Megan B.; Cohen, Ted;

Published:

Nov 2017

Source:

Emerg Infect Dis. 23(11):1887-1890.

Description:

Because within-host Mycobacterium tuberculosis diversity complicates diagnosis and treatment of tuberculosis (TB), we measured diversity prevalence and associated factors among 3,098 pulmonary TB patients in Lima, Peru. The 161 patients with polyclon...

File Type:

[PDF - 812.55 KB]
Pharmacokinetics and Dosing of Levofloxacin in Children Treated for Active or Latent Multidrug-Resistant Tuberculosis, Federated States of Micronesia and Republic of the Marshall Islands

Personal Author:

Mase, Sundari R.; Jereb, John A.; Gonzalez, Daniel; Martin, Fatma; Daley, Charles L.; Fred, Dorina; Loeffler, Ann; Menon, Lakshmy; Morris, Sapna Bamrah; Brostrom, Richard; Chorba, Terence; Peloquin, Charles A.;

Published:

Apr 2016

Source:

Pediatr Infect Dis J. 35(4):414-421.

Description:

Background : In the Federated States of Micronesia (FSM) and then the Republic of the Marshall Islands (RMI), levofloxacin pharmacokinetics (PK) were studied in children receiving directly observed once-daily regimens (10 mg/kg, age >5 years; 15�...

File Type:

[PDF - 1.64 MB]
Risk Factors for Acquisition of Drug Resistance during Multidrug-Resistant Tuberculosis Treatment, Arkhangelsk Oblast, Russia, 2005–2010

Personal Author:

Smith, Sarah E.; Ershova, Julia; Vlasova, Natalia; Nikishova, Elena; Tarasova, Irina; Eliseev, Platon; Maryandyshev, Andrey O.; Shemyakin, Igor G.; Kurbatova, Ekaterina; Cegielski, J. Peter;

Published:

Jun 2015

Source:

Emerg Infect Dis. 21(6):1002-1011.

Description:

Acquired resistance to antituberculosis drugs decreases effective treatment options and the likelihood of treatment success. We identified risk factors for acquisition of drug resistance during treatment for multidrug-resistant tuberculosis (MDR TB) ...

File Type:

[PDF - 2.09 MB]